1
|
Wang X, Cui C, Meng X, Han C, Wu B, Dou X, Zhao C, Zhang Y, Li K, Feng C. Chiral Supramolecular Hydrogel Enhanced Transdermal Delivery of Sodium Aescinate to Modulate M1 Macrophage Polarization Against Lymphedema. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2024; 11:e2303495. [PMID: 38037850 PMCID: PMC10837362 DOI: 10.1002/advs.202303495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 09/21/2023] [Indexed: 12/02/2023]
Abstract
Sodium aescinate (SA) shows great potential for treating lymphedema since it can regulate the expression of cytokines in M1 macrophages, however, it is commonly administered intravenously in clinical practice and often accompanied by severe toxic side effects and short metabolic cycles. Herein, SA-loaded chiral supramolecular hydrogels are prepared to prove the curative effects of SA on lymphedema and enhance its safety and transdermal transmission efficiency. In vitro studies demonstrate that SA- loaded chiral supramolecular hydrogels can modulate local immune responses by inhibiting M1 macrophage polarization. Typically, these chiral hydrogels can significantly increase the permeability of SA with good biocompatibility due to the high enantioselectivity between chiral gelators and stratum corneum and L-type hydrogels are found to have preferable drug penetration over D-type hydrogels. In vivo studies show that topical delivery of SA via chiral hydrogels results in dramatic therapeutic effects on lymphedema. Specifically, it can downregulate the level of inflammatory cytokines, reduce the development of fibrosis, and promote the regeneration of lymphatic vessels. This study initiates the use of SA for lymphedema treatment and for the creation of an effective chiral biological platform for improved topical administration.
Collapse
Affiliation(s)
- Xueqian Wang
- State Key Lab of Metal Matrix CompositesShanghai Key Laboratory for Molecular Engineering of Chiral DrugsSchool of Materials Science and EngineeringShanghai Jiao Tong UniversityShanghai200240China
| | - Chunxiao Cui
- Department of Burns and Plastic SurgeryShanghai Children's Medical CenterShanghai Jiao Tong UniversityShanghai200127China
| | - Xinxian Meng
- Department of Plastic and Reconstructive SurgeryShanghai Ninth People's HospitalShanghai Jiao Tong University School of MedicineShanghai200011China
| | - Chengyao Han
- Department of Plastic and Reconstructive SurgeryShanghai Ninth People's HospitalShanghai Jiao Tong University School of MedicineShanghai200011China
| | - Beibei Wu
- State Key Lab of Metal Matrix CompositesShanghai Key Laboratory for Molecular Engineering of Chiral DrugsSchool of Materials Science and EngineeringShanghai Jiao Tong UniversityShanghai200240China
| | - Xiaoqiu Dou
- State Key Lab of Metal Matrix CompositesShanghai Key Laboratory for Molecular Engineering of Chiral DrugsSchool of Materials Science and EngineeringShanghai Jiao Tong UniversityShanghai200240China
| | - Changli Zhao
- State Key Lab of Metal Matrix CompositesShanghai Key Laboratory for Molecular Engineering of Chiral DrugsSchool of Materials Science and EngineeringShanghai Jiao Tong UniversityShanghai200240China
| | - Yixin Zhang
- Department of Plastic and Reconstructive SurgeryShanghai Ninth People's HospitalShanghai Jiao Tong University School of MedicineShanghai200011China
| | - Ke Li
- Department of Plastic and Reconstructive SurgeryShanghai Ninth People's HospitalShanghai Jiao Tong University School of MedicineShanghai200011China
| | - Chuanliang Feng
- State Key Lab of Metal Matrix CompositesShanghai Key Laboratory for Molecular Engineering of Chiral DrugsSchool of Materials Science and EngineeringShanghai Jiao Tong UniversityShanghai200240China
| |
Collapse
|
2
|
Lv J, Ou X, Fang Y, Wu M, Zheng F, Shang L, Lei K, Liu Y, Zhao Y. The Study of Deep Eutectic Solvent Based on Choline Chloride and L-(+)-Tartaric Acid Diethyl Ester for Transdermal Delivery System. AAPS PharmSciTech 2022; 23:252. [PMID: 36076112 DOI: 10.1208/s12249-022-02342-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2022] [Accepted: 05/15/2022] [Indexed: 11/30/2022] Open
Abstract
Deep eutectic solvents (DESs) based on choline chloride (C) and L-(+)-tartaric acid diethyl ester (L) were prepared and used in transdermal drug delivery system (TDDS). The internal chemistry structure including the formation and changes of hydrogen bonds of choline chloride and L-(+)-tartaric acid diethyl ester DES was characterized via attenuated total reflection Fourier transform infrared (ATR-FTIR) and 1H nuclear magnetic resonance (1H NMR) spectroscopy. The stoichiometric ratio of choline chloride to L-(+)-tartaric acid diethyl ester as well as water content affected the viscosity, glass transition temperature (Tg), and drug solubility of the DES. The viscosity and glass transition temperature of the DES (CL14) prepared at the ratio of 1:4 of choline chloride to L-(+)-tartaric acid diethyl ester were 1.19 Pa·s and - 44.01°C, respectively, and decreased to 0.10 Pa·s and - 55.31°C when 10% water (CL1410) was added. Taking diclofenac diethylamine (DDEA), the nonsteroidal anti-inflammatory drug as model, drug solubility was as high as 60 mg/ml and 250 mg/ml in CL14 and CL1410, respectively. The cumulative amount of DDEA was 4.63 ± 2.67 μg/cm2 and 15.27 ± 4.63 μg/cm2 for CL14 and CL1410, respectively, at 8 h. The mechanism of percutaneous permeability by the DES may be the disturbance of stratum corneum (SC) lipids as well as changes in the protein conformations. CL14 and CL1410 were also verified as low-cytotoxic and nonirritant. Therefore, the DESs studied are promising to be used in drug solubilization enhancement and transdermal drug delivery system.
Collapse
Affiliation(s)
- Jianhua Lv
- Jihua Institute of Biomedical Engineering and Technology, Jihua Laboratory, Foshan, 528000, People's Republic of China
| | - Xiaoyu Ou
- Jihua Institute of Biomedical Engineering and Technology, Jihua Laboratory, Foshan, 528000, People's Republic of China
| | - Yaru Fang
- Jihua Institute of Biomedical Engineering and Technology, Jihua Laboratory, Foshan, 528000, People's Republic of China
| | - Mi Wu
- Jihua Institute of Biomedical Engineering and Technology, Jihua Laboratory, Foshan, 528000, People's Republic of China
| | - Fanghao Zheng
- Foshan Hospital of TCM, Foshan, Guangdong, 528000, People's Republic of China
| | - Lei Shang
- Jihua Institute of Biomedical Engineering and Technology, Jihua Laboratory, Foshan, 528000, People's Republic of China. .,Shenyang Medical College, Shenyang, 110034, People's Republic of China.
| | - Kaijun Lei
- Foshan Hospital of TCM, Foshan, Guangdong, 528000, People's Republic of China.
| | - Yunen Liu
- Jihua Institute of Biomedical Engineering and Technology, Jihua Laboratory, Foshan, 528000, People's Republic of China. .,Shenyang Medical College, Shenyang, 110034, People's Republic of China.
| | - Yan Zhao
- Jihua Institute of Biomedical Engineering and Technology, Jihua Laboratory, Foshan, 528000, People's Republic of China.
| |
Collapse
|
3
|
Khorshid S, Montanari M, Benedetti S, Moroni S, Aluigi A, Canonico B, Papa S, Tiboni M, Casettari L. A microfluidic approach to fabricate sucrose decorated liposomes with increased uptake in breast cancer cells. Eur J Pharm Biopharm 2022; 178:53-64. [DOI: 10.1016/j.ejpb.2022.07.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2022] [Revised: 07/19/2022] [Accepted: 07/27/2022] [Indexed: 11/04/2022]
|
4
|
Vlaia L, Olariu I, Muţ AM, Coneac G, Vlaia V, Anghel DF, Maxim ME, Stângă G, Dobrescu A, Suciu M, Szabadai Z, Lupuleasa D. New, Biocompatible, Chitosan-Gelled Microemulsions Based on Essential Oils and Sucrose Esters as Nanocarriers for Topical Delivery of Fluconazole. Pharmaceutics 2021; 14:75. [PMID: 35056971 PMCID: PMC8778122 DOI: 10.3390/pharmaceutics14010075] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Revised: 12/06/2021] [Accepted: 12/27/2021] [Indexed: 01/11/2023] Open
Abstract
Biocompatible gel microemulsions containing natural origin excipients are promising nanocarrier systems for the safe and effective topical application of hydrophobic drugs, including antifungals. Recently, to improve fluconazole skin permeation, tolerability and therapeutic efficacy, we developed topical biocompatible microemulsions based on cinnamon, oregano or clove essential oil (CIN, ORG or CLV) as the oil phase and sucrose laurate (D1216) or sucrose palmitate (D1616) as surfactants, excipients also possessing intrinsic antifungal activity. To follow up this research, this study aimed to improve the adhesiveness of respective fluconazole microemulsions using chitosan (a biopolymer with intrinsic antifungal activity) as gellator and to evaluate the formulation variables' effect (composition and concentration of essential oil, sucrose ester structure) on the gel microemulsions' (MEGELs) properties. All MEGELs were evaluated for drug content, pH, rheological behavior, viscosity, spreadability, in vitro drug release and skin permeation and antifungal activity. The results showed that formulation variables determined distinctive changes in the MEGELs' properties, which were nevertheless in accordance with official requirements for semisolid preparations. The highest flux and release rate values and large diameters of the fungal growth inhibition zone were produced by formulations MEGEL-FZ-D1616-CIN 10%, MEGEL-FZ-D1216-CIN 10% and MEGEL-FZ-D1616-ORG 10%. In conclusion, these MEGELs were demonstrated to be effective platforms for fluconazole topical delivery.
Collapse
Affiliation(s)
- Lavinia Vlaia
- Department II—Pharmaceutical Technology, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; (L.V.); (I.O.); (A.M.M.); (G.C.)
| | - Ioana Olariu
- Department II—Pharmaceutical Technology, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; (L.V.); (I.O.); (A.M.M.); (G.C.)
| | - Ana Maria Muţ
- Department II—Pharmaceutical Technology, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; (L.V.); (I.O.); (A.M.M.); (G.C.)
| | - Georgeta Coneac
- Department II—Pharmaceutical Technology, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; (L.V.); (I.O.); (A.M.M.); (G.C.)
| | - Vicenţiu Vlaia
- Department I—Organic Chemistry, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania
| | - Dan Florin Anghel
- “Ilie Murgulescu” Institute of Physical Chemistry of the Romanian Academy, Laboratory of Colloid Chemistry, 060021 Bucharest, Romania; (D.F.A.); (M.E.M.); (G.S.)
| | - Monica Elisabeta Maxim
- “Ilie Murgulescu” Institute of Physical Chemistry of the Romanian Academy, Laboratory of Colloid Chemistry, 060021 Bucharest, Romania; (D.F.A.); (M.E.M.); (G.S.)
| | - Gabriela Stângă
- “Ilie Murgulescu” Institute of Physical Chemistry of the Romanian Academy, Laboratory of Colloid Chemistry, 060021 Bucharest, Romania; (D.F.A.); (M.E.M.); (G.S.)
| | - Amadeus Dobrescu
- Department X Surgery 2–Surgery 2, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania;
| | - Maria Suciu
- Department II—Pharmacology and Pharmacotherapy, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania;
| | - Zoltan Szabadai
- National Institute for Research and Development in Electrochemistry and Condensed Matter, 300569 Timişoara, Romania;
| | - Dumitru Lupuleasa
- Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, Romania;
| |
Collapse
|
5
|
Nicotinic Amidoxime Derivate BGP-15, Topical Dosage Formulation and Anti-Inflammatory Effect. Pharmaceutics 2021; 13:pharmaceutics13122037. [PMID: 34959318 PMCID: PMC8707203 DOI: 10.3390/pharmaceutics13122037] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 11/24/2021] [Accepted: 11/25/2021] [Indexed: 12/19/2022] Open
Abstract
BGP-15 is a Hungarian-developed drug candidate with numerous beneficial effects. Its potential anti-inflammatory effect is a common assumption, but it has not been investigated in topical formulations yet. The aim of our study was to formulate 10% BGP-15 creams with different penetration enhancers to ensure good drug delivery, improve bioavailability of the drug and investigate the potential anti-inflammatory effect of BGP-15 creams in vivo. Since the exact mechanism of the effect is still unknown, the antioxidant effect (tested with UVB radiation) and the ability of BGP-15 to decrease macrophage activation were evaluated. Biocompatibility investigations were carried out on HaCaT cells to make sure that the formulations and the selected excipients can be safely used. Dosage form studies were also completed with texture analysis and in vitro release with Franz diffusion chamber apparatus. Our results show that the ointments were able to reduce the extent of local inflammation in mice, but the exact mechanism of the effect remains unknown since BGP-15 did not show any antioxidant effect, nor was it able to decrease LPS-induced macrophage activation. Our results support the hypothesis that BGP-15 has a potential anti-inflammatory effect, even if it is topically applied, but the mechanism of the effect remains unclear and requires further pharmacological studies.
Collapse
|
6
|
Scott LN, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. Safety Assessment of Saccharide Esters as Used in Cosmetics. Int J Toxicol 2021; 40:52S-116S. [PMID: 34514895 DOI: 10.1177/10915818211016378] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
This is a safety assessment of 40 saccharide ester ingredients as used in cosmetics. The saccharide esters are reported to function in cosmetics as emollients, skin-conditioning agents, fragrance ingredients, and emulsion stabilizers. The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the relevant data for these ingredients. The Panel concluded that the saccharide esters are safe in cosmetics in the present practices of use and concentrations described in this safety assessment.
Collapse
Affiliation(s)
- Laura N Scott
- 44002Cosmetic Ingredient Review Former Scientific Analyst/Writer
| | | | | | - Ronald A Hill
- Expert Panel for Cosmetic Ingredient Safety Former Member
| | | | | | - James G Marks
- Expert Panel for Cosmetic Ingredient Safety Former Member
| | | | | | | | | | | |
Collapse
|
7
|
Chu T, Wang C, Wang J, Wang H, Geng D, Wu C, Zhao L, Zhao L. Chiral 4- O-acylterpineol as transdermal permeation enhancers: insights of the enhancement mechanisms of a transdermal enantioselective delivery system for flurbiprofen. Drug Deliv 2021; 27:723-735. [PMID: 32397753 PMCID: PMC7269032 DOI: 10.1080/10717544.2020.1760403] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
In order to devise more effective penetration enhancers, 4-O-acylterpineol derivatives which were expected to be hydrolyzed into nontoxic metabolites by esterase in the living epidermis, were synthesized from 4-terpineol (4-TER) enantiomers and straight chain fatty acids. Their promoting activities on the SR-flurbiprofen and its enantiomers were tested across full-thickness rabbit skin, as well as to correlate under in vitro and in vivo conditions. The permeation studies indicated that both d-4-O-acylterpineol and l-4-O-acylterpineol had significant enhancing effects, interestingly, d-4-O-aclyterpineol had higher enhancing effects than l-4-O-aclyterpineol with the exception of d-4-methyl-1-(1-methylethyl)-3-cyclohexen-1-yl octadec-9-enoate (d-4-T-dC18). The mechanism of 4-O-acylterpineol facilitating the drug penetration across the skin was confirmed by Attenuated total reflection-Fourier transformed infrared spectroscopy (ATR-FTIR) and molecular simulation. The mechanism of penetration enhancers promoting drug release was explored by the in vitro release experiment. Finally, a relative safety skin irritation of enhancers was also investigated by in vivo histological evaluation. The present research suggested that d-4-O-aclyterpineol and l-4-O-aclyterpineol could significantly promote the penetration of SR-flurbiprofen and its enantiomers both in vitro and in vivo, with the superiorities of high flux and low dermal toxicity.
Collapse
Affiliation(s)
- Tianzhe Chu
- School of Pharmacy, North China University of Science and Technology, Tangshan, China
| | - Chunyan Wang
- Department of Pharmacy, Tangshan Maternal and Child Health Hospital, Tangshan, China
| | - Jing Wang
- School of Pharmacy, North China University of Science and Technology, Tangshan, China
| | - Heping Wang
- School of Pharmacy, North China University of Science and Technology, Tangshan, China
| | - Dandan Geng
- School of Pharmacy, North China University of Science and Technology, Tangshan, China
| | - Chensi Wu
- School of Pharmacy, North China University of Science and Technology, Tangshan, China
| | - Linlin Zhao
- School of Pharmacy, North China University of Science and Technology, Tangshan, China
| | - Ligang Zhao
- School of Pharmacy, North China University of Science and Technology, Tangshan, China.,Tangshan key laboratory of novel preparations and drug release technology, Tangshan, China
| |
Collapse
|
8
|
Liu C, Li J, Li K, Xie C, Liu J. Oxidized konjac glucomannan-cassava starch and sucrose esters as novel excipients for sustained-release matrix tablets. Int J Biol Macromol 2020; 156:1045-1052. [DOI: 10.1016/j.ijbiomac.2019.11.146] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2019] [Revised: 11/13/2019] [Accepted: 11/18/2019] [Indexed: 01/10/2023]
|
9
|
Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC). Int J Pharm 2020; 576:118918. [DOI: 10.1016/j.ijpharm.2019.118918] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Revised: 11/24/2019] [Accepted: 11/28/2019] [Indexed: 01/01/2023]
|
10
|
Abstract
Skin hydration is a complex process that influences the physical and mechanical properties of skin. Various technologies have emerged over the years to assess this parameter, with the current standard being electrical probe-based instruments. Nevertheless, their inability to provide detailed information has prompted the use of sophisticated spectroscopic and imaging methodologies, which are capable of in-depth skin analysis that includes structural and composition details. Modern imaging and spectroscopic techniques have transformed skin research in the dermatological and cosmetics disciplines, and are now commonly employed in conjunction with traditional methods for comprehensive assessment of both healthy and pathological skin. This article reviews current techniques employed in measuring skin hydration, and gives an account on their principle of operation and applications in skin-related research.
Collapse
|
11
|
Effects of sucrose ester structures on liposome-mediated gene delivery. Acta Biomater 2018; 72:278-286. [PMID: 29609051 DOI: 10.1016/j.actbio.2018.03.031] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2017] [Revised: 02/19/2018] [Accepted: 03/15/2018] [Indexed: 12/12/2022]
Abstract
Sucrose esters (SEs) have great potential applications in gene delivery because of their low toxicity, excellent biocompatibility, and biodegradability. By using tripeptide-based lipid (CDO) as a model lipid and SEs as helper lipids, a series of liposomes were prepared. The SEs with hydrophilic-lipophilic balance (HLB) values of 1, 6, 11, or 16 and the fatty acids of laurate, stearate, or oleate were used in the liposomes. We investigated the effect of HLB values of SEs and fatty acid types on gene transfection efficiency and toxicity of liposomes. The results showed that transfection efficiencies of the liposomes containing SEs with HLB value of 6 were superior to other liposomes in HeLa, MCF-7, NCI-H460, and A549 tumor cells. For the same HLB value, liposomes of laurate SEs were preferable to transfect cells compared to SEs of stearate and oleate. The liposomes with SEs showed higher cellular uptake than liposome without SEs (LipoCDO). LipoL12-6/Luc-siRNA treatment on tumor-bearing mice exhibited about 60% in vivo gene silencing of luciferase, and LipoL12-6 could mediate IGF-1R siRNA to greatly inhibit tumor growth. Moreover, liposomes with SEs revealed remarkably low toxicity in vitro and in vivo. The illustration of SE structures on gene delivery will promote the use of SEs for clinical trials of liposomes. STATEMENT OF SIGNIFICANCE This article is the first to study the effects of various chain lengths and hydrophilic-lipophilic balance (HLB) of sucrose esters (SEs) on gene transfection efficiency and safety of liposomes for gene delivery. The in vitro delivery of pDNA and siRNA by lipoplexes against HeLa, MCF-7, NCI-H460, and A549 tumor cells showed that the lipoplexes could lead to better transfection and lower cytotoxicity after the addition of SEs. SEs with shorter chain and a median HLB value could provide the liposomes with much higher gene transfection efficiency than others. The in vivo delivery of siRNA to tumor-bearing mice further confirmed that liposome containing laurate SE (LipoL12-6) could be a potential therapeutic vector, as it delivered siRNA to silence nearly 60% of the luciferase in tumors and also greatly inhibited the tumor growth. Therefore, the addition of SEs to liposomes proved to be relatively safe in vitro and in vivo. These preliminary results demonstrated that SEs show great potential for constructing controlled-release systems for gene delivery. The readers will get insights into a series of gene vectors and deepen their understanding about gene delivery.
Collapse
|
12
|
Xie WJ, Zhang YP, Xu J, Sun XB, Yang FF. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics. Molecules 2017; 22:molecules22040525. [PMID: 28346390 PMCID: PMC6154618 DOI: 10.3390/molecules22040525] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Revised: 03/09/2017] [Accepted: 03/22/2017] [Indexed: 01/06/2023] Open
Abstract
Background: In this paper, a new type of physical penetration technology for transdermal administration with traditional Chinese medicine (TCM) characteristics is presented. Fu’s cupping therapy (FCT), was established and studied using in vitro and in vivo experiments and the penetration effect and mechanism of FCT physical penetration technology was preliminarily discussed. Methods: With 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-ylacetic acid (indomethacin, IM) as a model drug, the establishment of high, medium, and low references was completed for the chemical permeation system via in vitro transdermal tests. Furthermore, using chemical penetration enhancers (CPEs) and iontophoresis as references, the percutaneous penetration effect of FCT for IM patches was evaluated using seven species of in vitro diffusion kinetics models and in vitro drug distribution; the IM quantitative analysis method in vivo was established using ultra-performance liquid chromatography-tandem mass spectrometry technology (UPLC-MS/MS), and pharmacokinetic parameters: area under the zero and first moment curves from 0 to last time t (AUC0–t, AUMC0–t), area under the zero and first moment curves from 0 to infinity (AUC0–∞, AUMC0–∞), maximum plasma concentration (Cmax) and mean residence time (MRT), were used as indicators to evaluate the percutaneous penetration effect of FCT in vivo. Additionally, we used the 3K factorial design to study the joint synergistic penetration effect on FCT and chemical penetration enhancers. Through scanning electron microscopy (SEM) and transmission electron microscope (TEM) imaging, micro- and ultrastructural changes on the surface of the stratum corneum (SC) were observed to explore the FCT penetration mechanism. Results: In vitro and in vivo skin permeation experiments revealed that both the total cumulative percutaneous amount and in vivo percutaneous absorption amount of IM using FCT were greater than the amount using CPEs and iontophoresis. Firstly, compared with the control group, the indomethacin skin percutaneous rate of the FCT low-intensity group (FCTL) was 35.52%, and the enhancement ratio (ER) at 9 h was 1.76X, roughly equivalent to the penetration enhancing effect of the CPEs and iontophoresis. Secondly, the indomethacin percutaneous ratio of the FCT middle-intensity group (FCTM) and FCT high-intensity group (FCTH) were 47.36% and 54.58%, respectively, while the ERs at 9 h were 3.58X and 8.39X, respectively. Thirdly, pharmacokinetic data showed that in vivo indomethacin percutaneous absorption of the FCT was much higher than that of the control, that of the FCTM was slightly higher than that of the CPE, and that of the FCTM group was significantly higher than all others. Meanwhile, variance analysis indicated that the combination of the FCT penetration enhancement method and the CPE method had beneficial effects in enhancing skin penetration: the significance level of the CPE method was 0.0004, which was lower than 0.001, meaning the difference was markedly significant; the significance level of the FCT was also below 0.0001 and its difference markedly significant. The significance level of factor interaction A × B was lower than 0.0001, indicating that the difference in synergism was markedly significant. Moreover, SEM and TEM images showed that the SC surfaces of Sprague-Dawley rats treated with FCT were damaged, and it was difficult to observe the complete surface structure, with SC pores growing larger and its special “brick structure” becoming looser. This indicated that the barrier function of the skin was broken, thus revealing a potentially major route of skin penetration. Conclusion: FCT, as a new form of transdermal penetration technology, has significant penetration effects with TCM characteristics and is of high clinical value. It is worth promoting its development.
Collapse
Affiliation(s)
- Wei-Jie Xie
- School of Pharmacy, Guiyang College of Traditional Chinese Medicine, No. 50 Shi Dong Road, Guiyang 550002, China.
| | - Yong-Ping Zhang
- School of Pharmacy, Guiyang College of Traditional Chinese Medicine, No. 50 Shi Dong Road, Guiyang 550002, China.
| | - Jian Xu
- School of Pharmacy, Guiyang College of Traditional Chinese Medicine, No. 50 Shi Dong Road, Guiyang 550002, China.
| | - Xiao-Bo Sun
- Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China.
| | - Fang-Fang Yang
- School of Pharmacy, Guiyang College of Traditional Chinese Medicine, No. 50 Shi Dong Road, Guiyang 550002, China.
| |
Collapse
|
13
|
Todosijević MN, Brezesinski G, Savić SD, Neubert RHH. Sucrose esters as biocompatible surfactants for penetration enhancement: An insight into the mechanism of penetration enhancement studied using stratumcorneum model lipids and Langmuir monolayers. Eur J Pharm Sci 2016; 99:161-172. [PMID: 27940082 DOI: 10.1016/j.ejps.2016.12.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Revised: 11/19/2016] [Accepted: 12/02/2016] [Indexed: 12/17/2022]
Abstract
Up to now, the molecular mechanism of the penetration enhancing effect of sucrose esters (SEs) on stratumcorneum (SC) has not been explained in details. In this study, variety of surface sensitive techniques, including surface pressure-area (π-A) isotherms, infrared reflection-absorption spectroscopy (IRRAS), and Brewster angle microscopy (BAM), have been used to investigate interactions between SEs and SC intercellular lipids. A monolayer of the mixture of ceramide AS C18:18, stearic acid and cholesterol in the molar ratio of 1:1:0.7 on an aqueous subphase is a good model to mimic a single layer of intercellular SC lipids. The π-A isotherms of mixed monolayers and parameters derived from the curves demonstrated the interaction between nonionic surfactants such as SEs and SC lipids. With increasing SE concentration, the resultant monolayer films became more fluid and better compressible. IRRAS measurements showed that SEs disordered the acyl chains of SC lipids, and the BAM images demonstrated the modification of the domain structures in SC monolayers. Longer chain-SE has a stronger disordering effect and is better miscible with ceramides in comparison to SE with a shorter hydrophobic part. In conclusion, this study demonstrates the disordering effect of SEs on the biomimetic SC model, pointing out that small changes in the structure of surfactant may have a strong influence on a penetration enhancement of lipophilic drugs through intercellular lipids of skin.
Collapse
Affiliation(s)
- Marija N Todosijević
- Department of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
| | | | - Snežana D Savić
- Department of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
| | - Reinhard H H Neubert
- Institute of Applied Dermatopharmacy at the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
| |
Collapse
|
14
|
Sucrose ester based cationic liposomes as effective non-viral gene vectors for gene delivery. Colloids Surf B Biointerfaces 2016; 145:454-461. [DOI: 10.1016/j.colsurfb.2016.05.033] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2016] [Revised: 04/16/2016] [Accepted: 05/11/2016] [Indexed: 01/01/2023]
|
15
|
Balázs B, Vizserálek G, Berkó S, Budai-Szűcs M, Kelemen A, Sinkó B, Takács-Novák K, Szabó-Révész P, Csányi E. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane. J Pharm Sci 2016; 105:1134-40. [DOI: 10.1016/s0022-3549(15)00172-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2015] [Revised: 10/27/2015] [Accepted: 11/19/2015] [Indexed: 10/22/2022]
|
16
|
Yutani R, Komori Y, Takeuchi A, Teraoka R, Kitagawa S. Prominent efficiency in skin delivery of resveratrol by novel sucrose oleate microemulsion. J Pharm Pharmacol 2016; 68:46-55. [DOI: 10.1111/jphp.12497] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2015] [Accepted: 10/17/2015] [Indexed: 12/23/2022]
Abstract
Abstract
Objectives
To achieve an efficient skin delivery of resveratrol using sucrose fatty acid ester microemulsions and to clarify the mechanism of enhanced penetration.
Methods
Skin delivery of resveratrol using different sucrose fatty acid ester microemulsions was examined in vitro. Vehicle–skin interaction was assessed by applying blank microemulsions to skin. Skin incorporation of microemulsion components was also assessed.
Key findings
The microemulsion consisting of sucrose oleate (SO), ethanol, isopropyl myristate (IPM) and water (MESO-E) showed a prominent increase in the amount of skin incorporation of resveratrol, which was more than 5-fold higher than those of all microemulsions we previously examined. Using MESO-E, resveratrol was rapidly incorporated into skin and mainly located in the dermis. When applied in the concentration range of 5–55 mm, the amount of skin incorporation of resveratrol increased with the applied concentration up to 30 mm, whereas skin incorporation efficiency was inversely proportional to the concentration. The microemulsion–skin interaction seemed to be involved in the enhanced skin delivery process of resveratrol by MESO-E. Stratum corneum modification due to the penetration of IPM, ethanol and SO is also involved in this interaction.
Conclusions
MESO-E would be a promising vehicle for the efficient skin delivery of resveratrol, especially when applied at a low concentration.
Collapse
Affiliation(s)
- Reiko Yutani
- Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan
| | - Yuka Komori
- Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan
| | - Atsuko Takeuchi
- Analytical Laboratory, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan
| | - Reiko Teraoka
- Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan
| | - Shuji Kitagawa
- Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan
| |
Collapse
|
17
|
Balázs B, Sipos P, Danciu C, Avram S, Soica C, Dehelean C, Varju G, Erős G, Budai-Szűcs M, Berkó S, Csányi E. ATR-FTIR and Raman spectroscopic investigation of the electroporation-mediated transdermal delivery of a nanocarrier system containing an antitumour drug. BIOMEDICAL OPTICS EXPRESS 2016; 7:67-78. [PMID: 26819818 PMCID: PMC4722911 DOI: 10.1364/boe.7.000067] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/02/2015] [Revised: 11/18/2015] [Accepted: 11/18/2015] [Indexed: 05/06/2023]
Abstract
The aim of the present work was the optimization of the transdermal delivery of a lyotropic liquid crystal genistein-based formulation (LLC-GEN). LLC was chosen as medium in view of the poor solubility of GEN in water. Membrane diffusion and penetration studies were carried out with a Franz diffusion cell, through a synthetic membrane in vitro, a chick chorioallantoic membrane ex ovo, and ex vivo excised human epidermis. Thereafter, LLC-GEN was combined with electroporation (EP) to enhance the transdermal drug delivery. The synergistic effect of EP was verified by in vivo ATR-FTIR and ex vivo Raman spectroscopy on hairless mouse skin.
Collapse
Affiliation(s)
- Boglárka Balázs
- Department of Pharmaceutical Technology, University of Szeged, Szeged, H-6720, Hungary
- Gedeon Richter Plc., Budapest, H-1103, Hungary
| | - Péter Sipos
- Department of Pharmaceutical Technology, University of Szeged, Szeged, H-6720, Hungary
| | - Corina Danciu
- Department of Pharmacognosy, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Stefana Avram
- Discipline of Pharmacology, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Codruta Soica
- Discipline of Pharmaceutical Chemistry, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Cristina Dehelean
- Department of Toxicology, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Gábor Varju
- Dr. Derm Clinic of Anti-Aging Dermatology, Aesthetic Laser and Plastic Surgery, Budapest, H-1026, Hungary
| | - Gábor Erős
- Department of Dermatology and Allergology, University of Szeged, Szeged, H-6720, Hungary
- Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, H-6720, Hungary
| | - Mária Budai-Szűcs
- Department of Pharmaceutical Technology, University of Szeged, Szeged, H-6720, Hungary
| | - Szilvia Berkó
- Department of Pharmaceutical Technology, University of Szeged, Szeged, H-6720, Hungary
| | - Erzsébet Csányi
- Department of Pharmaceutical Technology, University of Szeged, Szeged, H-6720, Hungary
| |
Collapse
|
18
|
Rodrigues LR. Microbial surfactants: Fundamentals and applicability in the formulation of nano-sized drug delivery vectors. J Colloid Interface Sci 2015; 449:304-16. [DOI: 10.1016/j.jcis.2015.01.022] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2014] [Revised: 01/11/2015] [Accepted: 01/12/2015] [Indexed: 12/29/2022]
|
19
|
Potential therapeutic applications of biosurfactants. Trends Pharmacol Sci 2013; 34:667-75. [PMID: 24182625 DOI: 10.1016/j.tips.2013.10.002] [Citation(s) in RCA: 195] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2013] [Revised: 10/01/2013] [Accepted: 10/03/2013] [Indexed: 12/20/2022]
Abstract
Biosurfactants have recently emerged as promising molecules for their structural novelty, versatility, and diverse properties that are potentially useful for many therapeutic applications. Mainly due to their surface activity, these molecules interact with cell membranes of several organisms and/or with the surrounding environments, and thus can be viewed as potential cancer therapeutics or as constituents of drug delivery systems. Some types of microbial surfactants, such as lipopeptides and glycolipids, have been shown to selectively inhibit the proliferation of cancer cells and to disrupt cell membranes causing their lysis through apoptosis pathways. Moreover, biosurfactants as drug delivery vehicles offer commercially attractive and scientifically novel applications. This review covers the current state-of-the-art in biosurfactant research for therapeutic purposes, providing new directions towards the discovery and development of molecules with novel structures and diverse functions for advanced applications.
Collapse
|
20
|
Erős G, Kurgyis Z, Németh IB, Csizmazia E, Berkó S, Szabó-Révész P, Kemény L, Csányi E. The Irritant Effects of Pharmaceutically Applied Surfactants. J SURFACTANTS DETERG 2013. [DOI: 10.1007/s11743-013-1444-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
21
|
Szűts A, Szabó-Révész P. Sucrose esters as natural surfactants in drug delivery systems--a mini-review. Int J Pharm 2012; 433:1-9. [PMID: 22575672 DOI: 10.1016/j.ijpharm.2012.04.076] [Citation(s) in RCA: 110] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2012] [Revised: 04/27/2012] [Accepted: 04/28/2012] [Indexed: 10/28/2022]
Abstract
Sucrose esters (SEs) are widely used in the food and cosmetic industries and there has recently been great interest in their applicability in different pharmaceutical fields. They are natural and biodegradable excipients with well-known emulsifying and solubilizing behavior. Currently the most common pharmaceutical applications of SEs are for the enhancement of drug dissolution and drug absorption/permeation, and in controlled-release systems. Although the number of articles on SEs is continuously increasing, they have not yet been widely used in the pharmaceutical industry. The aim of this review is to discuss and summarize some of the findings and applications of SEs in different areas of drug delivery. The article highlights the main properties of SEs and focuses on their use in pharmaceutical technology and on their regulatory and toxicological status.
Collapse
Affiliation(s)
- Angéla Szűts
- Department of Pharmaceutical Technology, University of Szeged, H-6720, Szeged, Eötvös u. 6, Hungary
| | | |
Collapse
|
22
|
Csizmazia E, Erős G, Berkesi O, Berkó S, Szabó-Révész P, Csányi E. Pénétration enhancer effect of sucrose laurate and Transcutol on ibuprofen. J Drug Deliv Sci Technol 2011. [DOI: 10.1016/s1773-2247(11)50066-8] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|